Scott Xiao,Endri Angjeli,Eric D Gaier et al.
Scott Xiao et al.
Re: Xiao et al.: Randomized controlled trial of a dichoptic digital therapeutic for amblyopia (Ophthalmology. 2022;129:77-85) [0.03%]
关于肖等人的随机对照试验：弱视的双眼前数字疗法(Ophthalmology. 2022;129:77-85)
Mirjana Bjeloš,Zdenko Sonicki,Mladen Bušić et al.
Mirjana Bjeloš et al.
Randomized Controlled Trial
Ophthalmology. 2022 Oct;129(10):e151-e152. DOI:10.1016/j.ophtha.2022.06.015 2022
Kai Lyn Goh,Fred K Chen,Chandrakumar Balaratnasingam et al.
Kai Lyn Goh et al.
Practice Patterns and Outcomes of Intravitreal Anti-VEGF Injection for Retinopathy of Prematurity: An International Multicenter Study [0.03%]
抗VEGF注射治疗早产儿视网膜病变的国际多中心研究及预后分析
Nimesh A Patel,Luis A Acaba-Berrocal,Sandra Hoyek et al.
Nimesh A Patel et al.
Purpose: To report practice patterns of intravitreal injections of anti-VEGF for retinopathy of prematurity (ROP) and outcomes data with a focus on retreatments and complications. ...
Multicenter Study
Ophthalmology. 2022 Dec;129(12):1380-1388. DOI:10.1016/j.ophtha.2022.07.009 2022
The Impact of Frailty Syndrome on Endogenous Endophthalmitis Development and Outcomes: A Population-Level Analysis [0.03%]
脆弱综合征对内源性眼内炎发病和结局的影响：基于人群的分析
Roger K Henry,Aditya Uppuluri,Marco A Zarbin et al.
Roger K Henry et al.
Purpose: Characterize the impact of frailty on endogenous endophthalmitis (EE) development and clinical outcomes among septicemic patients. Design: ...
Nationwide Emergency Medical Services Guidelines for Care of Ocular Emergencies [0.03%]
全国急诊医疗服务眼科急救指南
Margot A Gardin,Bella J Wolf,Peter A Kahn
Margot A Gardin
A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity [0.03%]
玻璃体腔内注射贝伐单抗、雷珠单抗、阿柏西普和激光治疗早产儿视网膜病变的再治疗率网络meta分析
Emer Chang,Amandeep S Josan,Ravi Purohit et al.
Emer Chang et al.
Topic: To compare bevacizumab, ranibizumab, aflibercept, and laser treatment as primary therapies for retinopathy of prematurity (ROP) in terms of retreatment rate. ...
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up [0.03%]
初切术与小梁切除术治疗5年后的疗效分析研究报告
Steven J Gedde,William J Feuer,Kin Sheng Lim et al.
Steven J Gedde et al.
Purpose: To report 5-year treatment outcomes in the Primary Tube Versus Trabeculectomy (PTVT) Study. Design: Multicenter randomized cli...
Randomized Controlled Trial
Ophthalmology. 2022 Dec;129(12):1344-1356. DOI:10.1016/j.ophtha.2022.07.003 2022
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up [0.03%]
小梁切除术与管状引流植入术5年随访后的并发症比较研究
Steven J Gedde,William J Feuer,Kin Sheng Lim et al.
Steven J Gedde et al.
Purpose: To describe postoperative complications encountered in the Primary Tube Versus Trabeculectomy (PTVT) Study during 5 years of follow-up. Design: ...
Randomized Controlled Trial
Ophthalmology. 2022 Dec;129(12):1357-1367. DOI:10.1016/j.ophtha.2022.07.004 2022